The Global Neurology Academy (GNA) Series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Examining Treatment Options for Insomnia: From Orexin to GABA
Examining Treatment Options for Insomnia: From Orexin to GABA
Integrating Evidence and Cultural Sensitivity in Patient-Centric Insomnia Treatments
Integrating Evidence and Cultural Sensitivity in Patient-Centric Insomnia Treatments
Negative Impacts of Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea
Negative Impacts of Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea
Roundtable: Experts Recommend Tools to Diagnose and Monitor Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Roundtable: Experts Recommend Tools to Diagnose and Monitor Excessive Daytime Sleepiness in Obstructive Sleep Apnea
The Epidemiology of Sleepiness in Obstructive Sleep Apnea
The Epidemiology of Sleepiness in Obstructive Sleep Apnea
How to Identify Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea
How to Identify Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Experts Debate: How Novel Excessive Daytime Sleepiness Treatments Fit Into Clinical Practice for Obstructive Sleep Apnea
Experts Debate: How Novel Excessive Daytime Sleepiness Treatments Fit Into Clinical Practice for Obstructive Sleep Apnea
Case Study: Adjusting STOP-BANG Screening Criteria for Minority Ethnic Groups
Case Study: Adjusting STOP-BANG Screening Criteria for Minority Ethnic Groups
New Treatments for Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea
New Treatments for Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Algorithm for Assessing Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Algorithm for Assessing Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment